Skip to main content

Abortion Pill Case Moves to Appeals Court

Medically reviewed by Drugs.com.

By Physician’s Briefing Staff HealthDay Reporter

WEDNESDAY, May 17, 2023 -- A ruling on the abortion pill mifepristone will be one step closer Wednesday when three federal judges hear arguments in the case.

The three judges at the 5th U.S. Circuit Court of Appeals in New Orleans have a history of supporting abortion restrictions, the Associated Press reported. They are not expected to rule immediately.

In November, abortion opponents in Texas filed a lawsuit in federal court, challenging the U.S. Food and Drug Administration approval of mifepristone in 2000. On April 7, U.S. District Judge Matthew Kacsmaryk issued a ruling that would have revoked approval of the drug. An appeal by the Biden administration and drugmaker Danco Laboratories led to a partial block of the ruling.

An appellate panel ruled that the abortion opponents were barred by time limits from challenging the 2000 approval. But it allowed limitations on changes the FDA had made since then, including on mailing the drug, according to the AP.

The U.S. Supreme Court put the lower court rulings on hold, pending appeal. That is likely to allow existing access to mifepristone into next year.

The FDA has revised its initial approval of mifepristone in recent years. It reduced the dosage needed to safely end pregnancy, allowed pills to be shipped by mail, and said an in-person doctor visit was not required. It also extended this option to 10 weeks of pregnancy. Previously, use of mifepristone was allowed only up to seven weeks of pregnancy, the AP reported.

Associated Press Article

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted May 2023

Read this next

Considerable Number of Abortion Seekers Accessed Services After Dobbs

MONDAY, March 25, 2024 -- Despite implementation of state-level bans and restrictions on abortion after the Supreme Court decision in Dobbs v. Jackson Women's Health Organization...

2020 to 2021 Saw Nonsignificant Decline in Perinatal Mortality Rate

THURSDAY, Dec. 7, 2023 -- A nonsignificant decline was seen in the U.S. perinatal mortality rate from 2020 to 2021, according to a December data brief published by the U.S...

CDC: 2020 to 2021 Saw Rise in Total Number, Rate, Ratio of Abortions

WEDNESDAY, Nov. 22, 2023 -- From 2020 to 2021, there were increases in the total number, rate, and ratio of reported abortions, according to research published in the Nov. 24...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.